Vanda Pharmaceuticals buy marge
Start price
30.10.17
/
50%
€14.03
Target price
04.11.21
€18.86
Performance (%)
11.22%
End price
05.11.21
€15.60
Summary
This prediction ended on 05.11.21 with a price of €15.60. The prediction had a final performance of 11.22%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vanda Pharmaceuticals | 5.576% | 5.576% | 21.497% | -18.126% |
| iShares Core DAX® | -0,05 % | 5,96 % | 7,40 % | 65,85 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % | 28,14 % | 93,30 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % | 48,89 % | 89,08 % |
| iShares S&P 500 | -0,36 % | 2,75 % | 22,53 % | 71,94 % |
Comments by marge for this prediction
In the thread Vanda Pharmaceuticals diskutieren
Vanda mit positiven Analystenkommentaren
- Vanda Pharmaceuticals (NASDAQ:VNDA) price target raised to $26 (77% upside) from $21 by Oppenheimer citing more bullish forecasts for Hetlioz (Outperform).
Kursziel geändert auf 18,864
In the thread Trading Vanda Pharmaceuticals
Die von marge gewählte maximale Laufzeit wurde überschritten